Chemoprevention
DHEA Analog/Fluasterone Enter Trials as Cancer Preventive
Published in Women's Health Weekly, January 27th, 1997
The synthetic version of DHEA is believed to be more effective and without the side effects of the natural steroid. Aeson Therapeutics Inc. (ATI), Tucson, Arizona, has supported the initial clinical development of fluasterone, a synthetic version of DHEA (dehydroepiandrosterone).
ATI designed its plan to show fluasterone's nonandrogenicity in humans and to establish its effectiveness in preventing breast cancer and treating other diseases such as lupus erythematosus and Type II diabetes.
Laboratory experiments suggest DHEA could...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- AIDS/HIV (Healthcare)
Program Provides Treatment for Prison-Released HIV-Positive Women - AIDS/HIV (Therapy)
Volunteers Needed for Alternative Medicine Study - AIDS/HIV (Vertical Transmission)
Treatment Supported for HIV Infected Pregnant Women with AZT - Breast Cancer (Funding)
Taxpayers Urged To Check Off Tax Forms To Donate to Breast Cancer - Breast Cancer (Genetic Testing)
UCSF Cancer Center to Offer Testing - Breast Cancer (Genetics)
'Switched On' Gene in Cancer Cells Remains 'Turned Off' in Normal Tissue - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
